Skip to main content

Biomedical Research Centre

The Biomedical Research Centre is a vibrant collaborative unit of molecular biologists, biochemists, chemists, clinicians, microbiologists, parasitologists, physiologists, and cell biologists.
The multidisciplinary research focuses on the analysis of the function of cells and organs in the human body and animal systems in physiological and pathological settings, focusing on cancer, inflammation, therapeutics and drug design, infectious diseases, pharmacology, physiology, immunology, molecular diagnostics and cell biology.
It also encompasses the perturbations caused by zoonotic and pathogenic microbes on human and animal health. BRC research sits within a rapidly developing area, which underpins our understanding and treatment of diseases and is developed with our partners in hospitals to generate better therapies. We continue to work closely with regional hospitals and wider national collaborations with universities and research centres, this includes KidScan Centre for Children’s Cancer Research, which focuses on new and improved treatments and other key areas like parasitology drug action and diagnostics for malaria. 

Latest news

Thu 27 Apr 2017

Salford leads on collaborative study of major trauma
THE UNIVERSITY of Salford in collaboration with Manchester Royal Infirmary, Salford Royal NHS Foundation Trust, University of Manchester and Waters Corporation Ltd are to carry out a cutting-edge study in a bid to improve clinical outcomes for patients admitted to hospital with major trauma. Forty-five per cent of post-admission major trauma deaths are caused by […]

Read full post...

Thu 20 Apr 2017

Politicians need training on ‘fake news’ – Professor
POLITICIANS may need to be trained to appreciate the role science plays in our lives and avoid falling for fake news, according to a Salford professor. Andy Miah is part of a national drive to reassert the science agenda after a series of setbacks for evidence-based ‘truth’ including US President Trump’s dismissal of one of […]

Read full post...

Wed 5 Apr 2017

New gene discovered driving cancer drug resistance
SCIENTISTS in Salford, UK, have identified a gene which is ‘revving the engine of cancer’ against the world’s most common breast cancer drug. For reasons unknown, 50% of patients with breast cancer treated with the estrogen receptor-blocking drug tamoxifen eventually become resistant to the treatment and cancer recurs. In a paper published this week in […]

Read full post...

Fri 17 Mar 2017

New role for immune cells in preventing diabetes and hypertension
A TYPE of immune cell which is reduced in number by obesity could be a new target to treat diseases such as type 2 diabetes and hypertension that affect overweight people, according to a collaborative study between the University of Salford, The University of Manchester and Lund University. In a study published in the journal […]

Read full post...

Fri 10 Mar 2017

Vitamin C effective in targeting cancer stem cells
VITAMIN C is up to ten times more effective at stopping cancer cell growth than pharmaceuticals such as 2-DG, according to scientists in Salford, UK. The research, published in Oncotarget, is the first evidence that Vitamin C (ascorbic acid) can be used to target and kill cancer stem cells (CSCs), the cells responsible for fuelling […]

Read full post...

Mon 7 Nov 2016

New insight into ‘perfect’ function of heart
AN INTERNATIONAL team of scientists have provided new insight into the Frank-Starling mechanism; a fundamental aspect of human heart function. The Frank-Starling mechanism described more than a century ago by Otto Frank and Ernest Starling – allows the volume of blood entering the heart to precisely match that ejected, because if a larger volume should […]

Read full post...